Reuters logo
BRIEF-Bioverativ and Bicycle Therapeutics enter into strategic research collaboration
September 6, 2017 / 6:54 AM / 15 days ago

BRIEF-Bioverativ and Bicycle Therapeutics enter into strategic research collaboration

Sept 6 (Reuters) - Bioverativ Inc-

* Bioverativ and Bicycle Therapeutics enter into strategic research collaboration to develop therapies for haemophilia and sickle cell disease

* Says Bicycle to receive an upfront payment of $10 million, with potential for future milestones

* Bioverativ Inc - upon execution of agreement, Bicycle will receive near-term research and development funding of $4.2 million

* Bioverativ Inc - Bicycle is eligible to receive up to $410 million related to development, regulatory ,commercialisation milestones

* Says additional terms of transaction are not being disclosed Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below